CD28 and acute lymphoblastic leukemia: Third‐generation CAR T cells incorporating the Toll/interleukin‐1 receptor (TIR) domain of Toll‐like receptor 2 (TLR2), together with the CD3ζ and CD28 intracellular domains, were administered to three patients with an extramedullary relapse of B‐ALL.